Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
08/2012
08/15/2012CN102639552A RNA monomers containing O-acetal levulinyl ester groups and their use in RNA microarrays
08/15/2012CN101348512B Antineoplastic ad virus preparation
08/15/2012CN101084233B Methods for reducing or eliminating alpha-mannosidase resistant glycans for the production of glycoproteins
08/14/2012US8242327 Reverse breeding
08/14/2012US8242257 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
08/14/2012US8242256 siRNA useful to supress expression of EIF-5A1
08/14/2012US8242255 Antisense oligonucleotides against cPLA2, compositions and uses thereof
08/14/2012US8242254 Compositions for use in identification of bacteria
08/14/2012US8242253 Nucleotide sequence of shrimp actin promoter and its use in genetic transformation biotechnology
08/14/2012US8242252 CD19 binding agents and uses thereof
08/14/2012US8242251 Unsymmetrical cyanine dimer compounds and their application
08/14/2012US8242250 Nucleic acid molecule encoding a cystine knot polypeptide
08/14/2012US8242249 Primer and probe for use in detection of Mycobacterium kansasii and method for detection of Mycobacterium kansasii using the same
08/14/2012US8242245 Fetal polypeptides from human liver
08/14/2012US8242244 Selective incorporation of 5-hydroxytryptophan into proteins in mammalian cells
08/14/2012US8242095 In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors
08/14/2012US8242094 siRNA of NF-kB p105 for inhibiting cell proliferation and migration and a composition comprising same
08/14/2012US8242091 for a disorder of a subject's heart involving loss of cardiomyocytes by administering an amount of an agent effective to cause cardiomyocyte proliferation within the subject's heart; Vitamin D3 Up-Regulated Protein-1; peroxiredoxin
08/14/2012US8242090 Vascular therapeutics
08/14/2012US8242086 Methods and compositions for treating disorders caused by a deficiency in a gene product of a CLN gene
08/14/2012US8242058 Reagents and methods for appending functional groups to proteins
08/14/2012US8241910 Plant raffinose saccharide biosynthetic enzymes
08/14/2012US8241899 Anti-TNF antibodies, compositions, methods and uses
08/14/2012US8241896 Compositions for use in recombinational cloning of nucelic acids
08/14/2012US8241893 Method and device for separating molecular targets in a complex mixture
08/14/2012US8241882 Hydrogen-producing bacterium, Clostridium perfringens
08/14/2012US8241879 Biological methods for preparing adipic acid
08/14/2012US8241877 Microorganisms for the production of methacrylic acid
08/14/2012US8241871 Cryptosporidium parvum antigens, antibodies thereto and diagnostic and therapeutic compositions thereof
08/14/2012US8241870 Mammalian expression vector with a highly efficient secretory signal sequence
08/14/2012US8241854 Triggered RNAi
08/14/2012US8241853 Primers and probes for detection and discrimination of types and subtypes of influenza viruses
08/14/2012US8241852 Unsymmetrical cyanine dimer compounds and their application
08/14/2012US8241851 Methods for nucleic acid manipulation
08/14/2012US8241850 Methods and compositions for isolating nucleic acid sequence variants
08/14/2012US8241849 Isolated genomic polynucleotide fragments that encode human lipoprotein-associated phospholipase A2
08/14/2012US8241844 Methods and compositions for modulating an immune response with immunogenic oligonucleotides
08/14/2012US8241628 Compositions and methods for antibodies targeting complement protein C5
08/14/2012CA2457485C Combination motif immune stimulatory oligonucleotides with improved activity
08/14/2012CA2449250C Regulation of lethal gene expression in plants
08/14/2012CA2251544C Cystatin b mutants
08/09/2012WO2012106725A2 Methods and compositions for treating occular disorders
08/09/2012WO2012106670A2 Expandable liquid volume in an led bulb
08/09/2012US20120204293 Glyphosate tolerant alfalfa events and methods for detection thereof
08/09/2012US20120204286 Ho/ll canola with resistance to clubroot disease
08/09/2012US20120204282 Methods and compositions for treating occular disorders
08/09/2012US20120204278 Animal models and therapeutic molecules
08/09/2012US20120204275 Apoe immunotherapy
08/09/2012US20120202983 Conjugates and Compositions for Cellular Delivery
08/09/2012US20120202982 Compositions and Methods for Therapy of Macular Degeneration
08/09/2012US20120202981 Novel guanosine-rich modified oligonucleotides and antiproliferative activity thereof
08/09/2012US20120202875 Method Of Treatment
08/09/2012US20120202874 Antisense oligonucleotide modulation of stat3 expression
08/09/2012US20120202873 RNAi Probes Targeting Cancer-Related Proteins
08/09/2012US20120202872 Methods and compositions for the diagnosis and prognosis of cervical intraepithelial neoplasia and cervical cancer
08/09/2012US20120202752 Antisense Oligonucleotides
08/09/2012US20120202748 Recombinant mussel adhesive protein fp-131
08/09/2012US20120202710 Methods and compositions for generation of germline human antibody genes
08/09/2012US20120202698 High throughput detection of molecular markers based on aflp and high through-put sequencing
08/09/2012US20120202397 Multi-site modified sp1 polypeptides and uses thereof
08/09/2012US20120202256 Novel preparation method of human metabolites of simvastatin or lovastatin using bacterial cytochrome p450 and composition therefor
08/09/2012US20120202214 Method for detecting fusion gene
08/09/2012US20120202207 Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma
08/09/2012US20120202204 Assay for Determining a Molecular Risk Assessment of a Complex Polymicrobial Sample Suspected to Contain an EHEC
08/09/2012US20120202201 Device and method for analysis of kidney failure
08/09/2012US20120202196 Labelled nucleotides
08/09/2012US20120202195 Nucleic acid element for use in analysis, and analytical method, analytical reagent, and analytical instrument using same
08/09/2012US20120201852 Vaccines Against Japanese Encephalitis Virus and West Nile Virus
08/09/2012US20120201848 Isolation of a virus related to canine parvovirus-2 from a raccoon
08/09/2012US20120201825 Chimeric poly peptides and the therapeutic use thereof against a flaviviridae infection
08/09/2012US20120201824 Compositions and Methods for Inhibiting an Oncogenic Protein to Enhance Immunogenicity
08/09/2012US20120201807 Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides
08/09/2012US20120199483 Nanopore capture system
08/09/2012DE102011009470A1 Biologisch wirksame Nukleotid-Moleküle zur gezielten Abtötung von Zellen, Verwendung derselben sowie Applikationskit Biologically active nucleotide molecules for targeted killing of cells, as well as using the same application kit
08/09/2012DE10113776B4 Isoliertes streptavidinbindendes, kompetitiv eluierbares Peptid, dieses umfassendes Fusionspeptid, dafür codierende Nukleinsäure, Expressionsvektor, Verfahren zur Herstellung eines rekombinanten Fusionsproteins und Verfahren zum Nachweis und/oder zur Gewinnung des Fusionsproteins An isolated streptavidinbindendes competitively elutable peptide, this complete fusion peptide, nucleic acid coding therefor, expression vector, to methods for producing a recombinant fusion protein, and methods for the detection and / or for the recovery of the fusion protein
08/09/2012CA2826420A1 Expandable liquid volume in an led bulb
08/08/2012EP2484774A2 Multiple gene expression including sorf contructs and methods with polyproteins, pro-proteins, and proteolysis
08/08/2012EP2484772A1 Methods for dynamic vector assembly of DNA cloning vector plasmids
08/08/2012EP2484763A2 Neukinase, a downstream protein of neuregulin
08/08/2012EP2484687A2 Methods and compositions for seamless cloning of nucleic acid molecules
08/08/2012EP2484671A1 Fluorescent molecule and method for detecting target nucleic acid
08/08/2012EP2483427A1 A clinical method for genotyping large genes for mutations that potentially cause disease
08/08/2012EP1940860B1 Methods for identifying biomarkers useful in diagnosis and/or treatment of biological states
08/08/2012EP1692282B1 Improved protein expression systems in auxotrophic Pseudomonas fluorescens
08/08/2012EP1635763B1 Method of treating neurodegenerative disease
08/08/2012EP1585760B1 Btl-ii nucleic acids, proteins, and antibodies
08/08/2012EP1478750B1 Gene expression by positive feedback activation of a cell type-specific promoter
08/08/2012EP1263769B1 Dna molecules encoding a chloride channel in drosophila melanogaster
08/08/2012CN1496412B Method for estimating danger of diabetes typ B developed in the human species of Chinese bloodline and composition
08/08/2012CN102630228A Methods, reagents and kits for detection of nucleic acid molecules
08/08/2012CN101516902B Polypeptides and polynucleotides encoding same and use thereof in the treatment of medical conditions associated with ischemia
08/08/2012CN101370817B Cationic oligonucleotides, automated methods for preparing same and their uses
08/08/2012CN101307310B Expression system with recombination protein for increasing yield and immunogenicity
08/07/2012US8237018 Promotes and methods thereof
08/07/2012US8236944 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
08/07/2012US8236943 Compositions and methods for silencing apolipoprotein B
08/07/2012US8236942 SiRNA targeting glucagon receptor (GCGR)
08/07/2012US8236941 Tetracycline repressor regulated oncolytic viruses
08/07/2012US8236940 Constitutive strong promoter and use thereof
08/07/2012US8236939 Micrornas and uses thereof
1 ... 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 ... 899